| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. (TVTX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 432.9K | $23.29M | - | |
| Other | 138.6K | $7.46M | - | |
| Other | 123.1K | $6.62M | - | |
| CFO | 116.9K | $6.29M | - | |
| Other | 111.5K | $6.00M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2020 | Clague Laura64 | Chief Financial Officer | Sell | 7,500 | $23.61 | $177,071.25 | -21.8% | |
| Nov 6, 2020 | Aselage Steve80 | Director | Sell | 23,125 | $22.81 | $527,525.00 | -4.9% | |
| Oct 5, 2020 | Heerma Peter53 | Chief Commercial Officer | Sell | 4,376 | $19.13 | $83,691.00 | -4.8% | |
| Sep 23, 2020 | Rosenberg Noah L. | Chief Medical Officer | Sell | 750 | $18.48 | $13,860.00 | -2.6% | |
| Sep 23, 2020 | Rote William E.58 | Senior Vice President, R&D | Sell | 1,500 | $18.48 | $27,720.00 | -5.9% | |
| Sep 23, 2020 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 1,500 | $18.48 | $27,720.00 | -5.6% | |
| Sep 23, 2020 | Clague Laura64 | Chief Financial Officer | Sell | 1,500 | $18.48 | $27,720.00 | -7.2% | |
| Sep 22, 2020 | Rote William E.58 | Senior Vice President, R&D | Sell | 1,500 | $18.59 | $27,885.00 | -5.5% | |
| Sep 22, 2020 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 1,500 | $18.59 | $27,885.00 | -5.3% | |
| Sep 22, 2020 | Clague Laura64 | Chief Financial Officer | Sell | 1,500 | $18.59 | $27,885.00 | -6.7% |